Interclean Shanghai

Lung Cancer Alliance Hails National Urban League Recent Endorsement of the Lung Cancer Mortality Red

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Hospital & Healthcare Management / Healthcare News / 15th Oct. 2010 :- Today, Lung Cancer Alliance (LCA), the only national organization providing patient support and advocacy for all those either living with or at risk for lung cancer, proudly announced the addition of the National Urban League to the growing roster of national organizations and institutions calling for a more comprehensive federal plan of action for lung cancer.

The National Urban League’s endorsement of the Lung Cancer Mortality Reduction Act, the first-ever federal legislation to fund a comprehensive, multi-agency plan targeted at lung cancer, brings added heft to this legislative call to action.

The National Urban League, which is celebrating its 100-year anniversary, is recognized as the nation’s leading social justice organization and is known for its efforts to close equality gaps which exist for African Americans and other emerging ethnic communities in education, economic empowerment, health and quality of life, civic rights and racial justice.

"This is tremendous news for the lung cancer community," said Laurie Fenton Ambrose, President  & CEO.  "National Urban League has a long and respected track record as a national champion of social justice issues – and at its core lung cancer is about social justice."

Lung cancer is the leading cause of cancer death in women and men and in every ethnic group.    African American males have the highest incidence and mortality rate in relation to other Caucasian, Asian, Hispanic and Native American counterparts.   

"One of my priorities since taking the helm of the National Urban League’s Policy Institute was to sharpen our focus on health disparities," said Chanelle Hardy, Senior Vice President and Executive Director of the National Urban League Policy Institute.  "And that is what the Lung Cancer Mortality Act does for our community.  For that reason we are pleased to stand with so many other social justice leaders and national organizations calling for a more compassionate and comprehensive approach to addressing lung cancer."

The Lung Cancer Mortality Reduction Act, S.332 and HR 2112, calls for lung cancer to be made a national public health priority and requires the Departments of Health and Human Services, Defense and Veterans Affairs to coordinate on a comprehensive plan of action that will address all aspects of the disease.

Lung Cancer Alliance (www.LungCancerAlliance.org) is the only national non-profit organization dedicated exclusively to patient support and advocacy for those living with or at risk for lung cancer.  Lung Cancer Alliance is committed to leading the movement to reverse decades of stigma and neglect by empowering those with or at risk for the disease, elevating awareness and changing health policy.

Media Contact:
   
Kay Cofrancesco

kay@lungcanceralliance.org
   
202-463-2080

SOURCE Lung Cancer Alliance
RELATED LINKS
http://www.lungcanceralliance.org

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »